欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号AT/H/0849/001
药品名称Nolpaza Control 20 mg magensaftresistente Tabletten
活性成分
    • Pantoprazole sodium sesquihydrate 20.0 mg
剂型Gastro-resistant capsule*
上市许可持有人Krka, d.d., Novo mesto, Šmarješka cesta 6, 8501 Novo mesto, Slovenia
参考成员国 - 产品名称Austria (AT)
Nolpaza Control 20 mg magensaftresistente Tabletten
互认成员国 - 产品名称
    • United Kingdom (Northern Ireland) (XI)
      Pantoprazole control Krka 20 mg gastro-resistant tablets
    • Ireland (IE)
    • Italy (IT)
    • Latvia (LV)
      Nolpacid 20 mg zarnās šķīstošās tabletes
    • Bulgaria (BG)
      Pantoprazol control Krka
许可日期2013/10/18
最近更新日期2024/11/15
药物ATC编码
    • A02BC02 pantoprazole
申请类型
  • TypeLevel1:[not specified]
  • TypeLevel2:[not specified]
  • TypeLevel3:[not specified]
  • TypeLevel4:[not specified]
  • TypeLevel5:[not specified]
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase